Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoon Ho Ko

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Cancer Research and Treatment|December 26, 2018
Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric CancerJin Won Kim, Jong Gwang Kim, Byung Woog Kang, et al.
Journal of Gastric Cancer|May 2, 2023
A Randomized Phase III Study of Patients With Advanced Gastric Adenocarcinoma Without Progression After Six Cycles of XELOX (Capecitabine Plus Oxaliplatin) Followed by Capecitabine Maintenance or Clinical ObservationGuk Jin Lee, Hyunho Kim, Sung Shim Cho, et al.
Cancers|July 9, 2020
Prognostic Value of <i>CD200R1</i> mRNA Expression in Head and Neck Squamous Cell CarcinomaHyun Chang, Yun-Gyoo Lee, Yoon Ho Ko, et al.
Experimental & Molecular Medicine|July 23, 2016
Genetic-pathologic characterization of myeloproliferative neoplasmsYonggoo Kim, Joonhong Park, Irene Jo, et al.
Cancer Research and Treatment|January 18, 2019
Prospective Validation of The Korean Cancer Study Group Geriatric Score (KG)-7, a Novel Geriatric Screening Tool, in Older Patients with Advanced Cancer Undergoing First-line Palliative ChemotherapyJin Won Kim, Se Hyun Kim, Yun-Gyoo Lee, et al.
The Oncologist|October 30, 2015
Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21Hyo Jung Kim, Sang Won Shin, Eun-Kee Song, et al.
British Journal of Cancer|March 27, 2018
Predicting cumulative incidence of adverse events in older patients with cancer undergoing first-line palliative chemotherapy: Korean Cancer Study Group (KCSG) multicentre prospective studyJin Won Kim, Yun-Gyoo Lee, In Gyu Hwang, et al.
The Oncologist|March 13, 2020
Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative ChemotherapySoojung Hong, Ju Hyun Lee, Eun Kyeong Chun, et al.
Cancers|January 22, 2021
Prevalence and Predictive Factors for Upfront Dose Reduction of the First Cycle of First-Line Chemotherapy in Older Adults with Metastatic Solid Cancer: Korean Cancer Study Group (KCSG) Multicenter StudyIn Gyu Hwang, Minsuk Kwon, Jin Won Kim, et al.
Cancer Research and Treatment|July 4, 2023
Lazertinib versus Gefitinib as First-Line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean SubsetKi Hyeong Lee, Byoung Chul Cho, Myung-Ju Ahn, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Cancer Research and Treatment|December 26, 2018
Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric CancerJin Won Kim, Jong Gwang Kim, Byung Woog Kang, et al.
Journal of Gastric Cancer|May 2, 2023
A Randomized Phase III Study of Patients With Advanced Gastric Adenocarcinoma Without Progression After Six Cycles of XELOX (Capecitabine Plus Oxaliplatin) Followed by Capecitabine Maintenance or Clinical ObservationGuk Jin Lee, Hyunho Kim, Sung Shim Cho, et al.
Cancers|July 9, 2020
Prognostic Value of <i>CD200R1</i> mRNA Expression in Head and Neck Squamous Cell CarcinomaHyun Chang, Yun-Gyoo Lee, Yoon Ho Ko, et al.
Experimental & Molecular Medicine|July 23, 2016
Genetic-pathologic characterization of myeloproliferative neoplasmsYonggoo Kim, Joonhong Park, Irene Jo, et al.
Cancer Research and Treatment|January 18, 2019
Prospective Validation of The Korean Cancer Study Group Geriatric Score (KG)-7, a Novel Geriatric Screening Tool, in Older Patients with Advanced Cancer Undergoing First-line Palliative ChemotherapyJin Won Kim, Se Hyun Kim, Yun-Gyoo Lee, et al.
The Oncologist|October 30, 2015
Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21Hyo Jung Kim, Sang Won Shin, Eun-Kee Song, et al.
British Journal of Cancer|March 27, 2018
Predicting cumulative incidence of adverse events in older patients with cancer undergoing first-line palliative chemotherapy: Korean Cancer Study Group (KCSG) multicentre prospective studyJin Won Kim, Yun-Gyoo Lee, In Gyu Hwang, et al.
The Oncologist|March 13, 2020
Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative ChemotherapySoojung Hong, Ju Hyun Lee, Eun Kyeong Chun, et al.
Cancers|January 22, 2021
Prevalence and Predictive Factors for Upfront Dose Reduction of the First Cycle of First-Line Chemotherapy in Older Adults with Metastatic Solid Cancer: Korean Cancer Study Group (KCSG) Multicenter StudyIn Gyu Hwang, Minsuk Kwon, Jin Won Kim, et al.
Cancer Research and Treatment|July 4, 2023
Lazertinib versus Gefitinib as First-Line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean SubsetKi Hyeong Lee, Byoung Chul Cho, Myung-Ju Ahn, et al.
Pageof 11